 Cubist Systematic Strategies LLC increased its position in Five Prime Therapeutics Inc NASDAQ:FPRX by 106.4 in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission SEC. The firm owned 22,818 shares of the biotechnology companys stock after purchasing an additional 11,764 shares during the quarter. Cubist ... 